Molecular Endoscopy for the Diagnosis and Therapeutic Monitoring of Colorectal Cancer.

Raman adenoma colorectal cancer confocal endomicroscopy endoscopy fluorescence molecular imaging near-infrared imaging

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2022
Historique:
received: 14 12 2021
accepted: 26 01 2022
entrez: 14 3 2022
pubmed: 15 3 2022
medline: 15 3 2022
Statut: epublish

Résumé

Colorectal cancer (CRC) is one of the leading causes of cancer related death in the western world. Its successful treatment requires early detection and removal of precursor lesions as well as individualized treatment of advanced disease. During recent years, molecular imaging techniques have shown promising results to improve current clinical practice. For instance, molecular endoscopy resulted in higher detection rates of precursors in comparison to conventional endoscopy in preclinical and clinical studies. Molecular confocal endomicroscopy allowed a further classification of suspect lesions as well as the prediction and monitoring of the therapeutic response. In this review, we summarize recent achievements for molecular imaging of CRC in preclinical studies, initial clinical trials and the remaining challenges for future translation into clinical practice.

Identifiants

pubmed: 35280747
doi: 10.3389/fonc.2022.835256
pmc: PMC8913894
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

835256

Informations de copyright

Copyright © 2022 Waldner and Neurath.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Gastrointest Cancer Res. 2012 Jan;5(1):19-27
pubmed: 22574233
Semin Nucl Med. 2002 Apr;32(2):84-91
pubmed: 11965603
Endoscopy. 2013 Jun;45(6):469-77
pubmed: 23580409
Nat Rev Gastroenterol Hepatol. 2013 Dec;10(12):704-12
pubmed: 23856892
J Biomed Opt. 2018 Oct;24(3):1-14
pubmed: 30358334
N Engl J Med. 2017 Jan 12;376(2):149-156
pubmed: 28076720
Nat Rev Clin Oncol. 2018 Jan 23;15(3):150
pubmed: 29358775
Digestion. 2021;102(1):57-64
pubmed: 33271567
Mol Imaging. 2003 Oct;2(4):350-7
pubmed: 14717334
J Biomed Opt. 2015;20(9):096015
pubmed: 26397238
PLoS One. 2017 Jun 30;12(6):e0180509
pubmed: 28666016
Radiology. 2007 Jul;244(1):232-8
pubmed: 17507718
Endoscopy. 2010;42 Suppl 2:E314-5
pubmed: 21113888
Theranostics. 2018 Feb 5;8(6):1458-1467
pubmed: 29556334
Gastroenterology. 2019 May;156(6):1661-1674.e11
pubmed: 30738046
Int J Cancer. 2015 Mar 1;136(5):1095-103
pubmed: 25052906
Nat Med. 2008 Apr;14(4):454-8
pubmed: 18345013
Biomed Opt Express. 2018 Nov 13;9(12):6186-6204
pubmed: 31065422
Mol Oncol. 2012 Apr;6(2):182-95
pubmed: 22469618
Am J Gastroenterol. 2006 Feb;101(2):343-50
pubmed: 16454841
Nat Med. 2015 Nov;21(11):1350-6
pubmed: 26457759
Inflamm Bowel Dis. 2016 Jan;22(1):82-91
pubmed: 26457379
Gut. 2013 Aug;62(8):1179-86
pubmed: 22698650
Radiology. 2012 Jun;263(3):633-43
pubmed: 22623690
Dig Endosc. 2018 Nov;30(6):730-738
pubmed: 30075487
Cancer Res. 2010 May 1;70(9):3618-27
pubmed: 20430759
J Biomed Opt. 2012 Feb;17(2):021103
pubmed: 22463021
Cancer Sci. 2019 Jun;110(6):1921-1930
pubmed: 30973663
Oncotarget. 2016 Apr 5;7(14):17773-89
pubmed: 26894861
Gut. 2010 Aug;59(8):1046-55
pubmed: 20639250
Physiol Rev. 2012 Apr;92(2):897-965
pubmed: 22535898
Gastroenterology. 2004 Sep;127(3):706-13
pubmed: 15362025
Biomed Opt Express. 2013 Dec 04;5(1):78-92
pubmed: 24466478
Cell. 1990 Jun 1;61(5):759-67
pubmed: 2188735
AAPS J. 2009 Jun;11(2):286-99
pubmed: 19415506
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Mol Imaging Biol. 2016 Dec;18(6):820-829
pubmed: 27154508
Nature. 2008 Apr 3;452(7187):580-9
pubmed: 18385732
Gastroenterology. 2017 Apr;152(5):1002-1013.e9
pubmed: 28012848
Nat Med. 2015 Aug;21(8):955-61
pubmed: 26168295
Mol Imaging Biol. 2015 Aug;17(4):450-60
pubmed: 25622811
J Nucl Med. 2016 Mar;57(3):480-5
pubmed: 26678613
Clin Cancer Res. 2008 Nov 15;14(22):7413-22
pubmed: 19010858
Diagn Ther Endosc. 2013;2013:250641
pubmed: 23401648
Gastroenterology. 2002 Feb;122(2):406-14
pubmed: 11832455
J Biomed Opt. 2013 Sep;18(9):096008
pubmed: 24008818
Gastroenterology. 2010 Mar;138(3):828-33.e1
pubmed: 20096697
Gastroenterology. 2010 Feb;138(2):435-46
pubmed: 19852961
PLoS One. 2015 Apr 29;10(4):e0123185
pubmed: 25923788
Nat Rev Cancer. 2017 Feb;17(2):79-92
pubmed: 28050011

Auteurs

Maximilian J Waldner (MJ)

Department of Medicine 1, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Deutsches Zentrum Immuntherapie (DZI), Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.

Markus F Neurath (MF)

Department of Medicine 1, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Deutsches Zentrum Immuntherapie (DZI), Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.

Classifications MeSH